On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

Luxembourg's Ministry of Health and Social Security has reported that a safety notice regarding certain models... }} ...

Baxter will share an update on Hurricane Helene’s impact, while Medtronic will likely discuss a new pulsed field ablation ...

VMPL New Delhi [India] November 7 Medtronic a global leader in healthcare technology unveiled results from the Prospective ...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G ...

The U.S. Food and Drug Administration on Thursday announced a Class 1 recall for Medtronic MiniMed 600- and 700-series insulin pumps because of an increased risk of shorter battery life that could ...

Opens in a new tab or window A shorter-than-expected battery life prompted a voluntary recall of certain insulin pumps from Medtronic's MiniMed 600 and 700 series, the FDA detailed on Thursday.

The pulse oximeter, a device that measures the degree to which red blood cells are saturated with oxygen, is one of healthcare’s most fundamental tools.

Medtronic’s cardiovascular and neuroscience segments show steady mid-single-digit growth annually. Recent recalls of insulin pumps may hinder growth in Medtronic's diabetes business, despite ...